MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-07-0016315
Elbrit Life Sciences Private Limited - pharma in Erode, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹41.77 Cr
▲ 39% YoY
Net profit · FY 2024
₹1.16 Cr
Net margin 2.8%
EBITDA · FY 2024
₹3.05 Cr
EBITDA margin 7.3%
Authorised capital
₹80 Lakh
Registered with MCA
Paid-up capital
₹75.2 Lakh
Issued & subscribed
Open charges
₹10.28 Cr
Satisfied ₹9.4 Cr
Company age
12 yrs
Est. 2014
Employees · EPFO
213
Provident fund records
About Elbrit Life Sciences Private Limited
Data last updated:
Elbrit Life Sciences Private Limited is a private limited company based in Erode, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U74999TZ2014PTC029965. Its GSTIN is 33AADCE5937C1ZY (Tamil Nadu). The company holds 11 GST registrations, of which 8 are active.
The company has an authorised share capital of ₹80 Lakh and a paid-up capital of ₹75.2 Lakh. It is led by directors including Kailasanathan Senthilkumar Prakash (Managing Director) and Karukkupalayam Murugesan Nivedha (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 22/1 Perundurai Road, Erode, Tamil Nadu, India – 638011.
As per the financials filed for FY 2024, the company reported a revenue of ₹41.77 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹1.16 Cr (net margin 2.8%) and EBITDA of ₹3.05 Cr (EBITDA margin 7.3%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 26% over five years.
The company has about 213 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Elbrit Life Sciences. As per MCA filings, the company has open charges of ₹10.28 Cr and satisfied charges of ₹9.4 Cr on record. Court records list 20 cases involving the company, including 19 filed by the company; 1 case is pending. The company has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹10 Lakh; the latest was in June 2017. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Supercure Biotech Private Limited with revenue of ₹42.03 Cr.
Elbrit Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-07-0016315). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elbrit.org.
Company Details of Elbrit Life Sciences Private Limited
CIN U74999TZ2014PTC029965
Registration Number 029965
Incorporation Date 18 January 2014
ROC Coimbatore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-07-0016315
CIN History of Elbrit Life Sciences Private Limited
Elbrit Life Sciences has one previous CIN (Corporate Identification Number): U74999MH2014PTC252228. The current CIN is U74999TZ2014PTC029965, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999TZ2014PTC029965 | Current |
| U74999MH2014PTC252228 | Previous |
Key People
Kailasanathan Senthilkumar Prakash Managing Director Karukkupalayam Murugesan Nivedha Whole-Time Director Senthilkumar Kailasanathan Whole-Time Director Recognitions & Rankings of Elbrit Life Sciences
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address22/1 Perundurai Road, Erode, Tamil Nadu, India – 638011
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Elbrit Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Elbrit Life Sciences Private Limited
Elbrit Life Sciences operates one associated brand: Elbrit Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops, manufactures, and distributes innovative medications for various health conditions worldwide. | elbrit.org |
Business Activity of Elbrit Life Sciences Private Limited
The main business activity of Elbrit Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Elbrit Life Sciences Private Limited FY 2024 filings available
Elbrit Life Sciences Private Limited reported revenue of ₹41.77 Cr (up 39% YoY) for FY 2024.
Revenue · FY 2024
₹41.77 Cr ▲ 39%
Net profit · FY 2024
₹1.16 Cr margin 2.8%
EBITDA · FY 2024
₹3.05 Cr margin 7.3%
Compounded Annual Growth Rate (CAGR) of Elbrit Life Sciences Private Limited
Revenue CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 42%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 71%
3 years · compounded
▲ 63%
5 years · compounded
▲ 36%
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 39% growth in the latest year. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Elbrit Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.05 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.16 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Elbrit Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Elbrit Life Sciences are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Elbrit Life Sciences Private Limited
Elbrit Life Sciences has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Muruhgesan Marappagounder | Director | 30 Aug 2024 | 2 Years 1 Months | Current |
| Karukkupalayam Murugesan Nivedha | Whole-Time Director | 09 Apr 2021 | 5 Years 6 Months | Current |
| Senthilkumar Kailasanathan Also directs: Etsu Healthcare Private Limited | Whole-Time Director | 18 Jan 2014 | 12 Years 9 Months | Current |
| Kailasanathan Senthilkumar Prakash Also directs: Etsu Healthcare Private Limited, Nex Infracon Private Limited | Managing Director | 18 Jan 2014 | 12 Years 9 Months | Current |
Peer Comparison of Elbrit Life Sciences Private Limited
Elbrit Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Supercure Biotech Private Limited | ₹42.03 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Delhi, India |
| International Ingredients & Excipients Private Limited | ₹41.96 Cr (FY 2025) | •••• | •••• | 58.0% | •••• | Chennai, Tamil Nadu, India |
| Samrudh Pharmacare Private Limited | ₹41.88 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Mediart Lifesciences Private Limited | ₹41.86 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | New Delhi, Delhi, India |
| Aap Pharma Technologies India Private Limited | ₹41.83 Cr (FY 2024) | •••• | •••• | -13.0% | •••• | Hyderabad, Telangana, India |
| Elbrit Life Sciences Private Limited this company | ₹41.77 Cr (FY 2024) | •••• | •••• | 39.0% | •••• | Erode, Tamil Nadu, India |
| Crest Lifesciences Private Limited | ₹41.71 Cr (FY 2025) | •••• | •••• | 397.0% | •••• | Baddi, Himachal Pradesh, India |
| Pregio Pharma Private Limited | ₹41.7 Cr (FY 2024) | •••• | •••• | 34.0% | •••• | Chennai, Tamil Nadu, India |
| P.B.P Enterprises Private Limited | ₹41.67 Cr (FY 2025) | •••• | •••• | 68.0% | •••• | Mumbai, Maharashtra, India |
| Strava Healthcare Private Limited | ₹41.58 Cr (FY 2025) | •••• | •••• | 115.0% | •••• | Ahmedabad, Gujarat, India |
| SSM Formulations Private Limited | ₹41.41 Cr (FY 2024) | •••• | •••• | -19.0% | •••• | Hinganghat, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Elbrit Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Elbrit Life Sciences Private Limited
Elbrit Life Sciences Private Limited is audited by S DEEPAK for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S DEEPAK | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Elbrit Life Sciences Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Elbrit Life Sciences Private Limited
Open charges
₹10.28 Cr
Satisfied charges
₹9.4 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2025 | Hdfc Bank Limited | ₹38.4 Lakh | Open |
| 18 Mar 2025 | Hdfc Bank Limited | ₹16.56 Lakh | Open |
| 22 Nov 2024 | Others | ₹8 Cr | Open |
| 14 May 2024 | Hdfc Bank Limited | ₹38.77 Lakh | Open |
| 08 Mar 2023 | Hdfc Bank Limited | ₹23.18 Lakh | Open |
Total charge records: 12 View all charges
Deals & Funding of Elbrit Life Sciences Private Limited
Elbrit Life Sciences Private Limited has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹10 Lakh; the latest was in June 2017.
Total deals
2
Rights issue
1
Funding round
1
Disclosed funding
₹10 Lakh
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2017 | Rights issue | ₹20 Lakh | Investors: 2 individuals |
| Jan 2014 | Funding round | ₹10 Lakh | Investors: 2 individuals |
Premium access
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Elbrit Life Sciences Private Limited
Elbrit Life Sciences Private Limited has 20 court cases on record: 19 filed by Elbrit Life Sciences, 1 where it is another party. 1 case is pending and 19 are disposed. Status as checked between 21 Sep 2026 and 01 Oct 2026.
Total cases
20
Filed by the company
19
Pending
1
Disposed
19
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 15 | 0 | 0 |
| District courts | 5 | 0 | 1 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal miscellaneous application | Company is another party | Pending |
| Madras High Court | Interim or miscellaneous application | Filed by the company against Assistant Commissioner (St) | Disposed |
| Madras High Court | Writ petition | Filed by the company against Assistant Commissioner (St) | Disposed |
| District court, Erode, Tamil Nadu | Criminal miscellaneous application | Filed by the company | Disposed |
| District court, Erode, Tamil Nadu | Criminal case | Filed by the company against an individual | Disposed |
Premium access
Full case history
All 20 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Elbrit Life Sciences Private Limited
Elbrit Life Sciences Private Limited has a workforce of 213 employees as of Apr 08, 2024.
Employee count
213
Active EPFO establishments
1
Employee growth
54.35%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Elbrit Life Sciences Private Limited
Elbrit Life Sciences has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key Subsidiaries
| Company Name | CIN | Shares Held |
|---|---|---|
| Etsu Healthcare Private Limited | U24299MH2020PTC337963 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity on Elbrit Life Sciences Private Limited
Elbrit Life Sciences Private Limited has 8 board changes on record since 2014: 4 appointments and 4 cessations. The latest: Muruhgesan Marappagounder ceased to be Additional Director on 29 Sep 2024.
Charges
A charge registered on 25 Sep 2019 via Charge ID 100295013 with The South Indian Bank Limited was fully satisfied on 20 Nov 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 38.40 Lakh with Charge ID 101112221 was registered on 23 Jun 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 16.56 Lakh with Charge ID 101073441 was registered on 18 Mar 2025.
Charges
A charge with Others amounted to Rs. 800.00 Lakh with Charge ID 101016294 was registered on 22 Nov 2024.
AGM
Elbrit Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Muruhgesan Marappagounder ceased to be Additional Director.
Appointed
Muruhgesan Marappagounder was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 38.77 Lakh with Charge ID 100921904 was registered on 14 May 2024.
Filing
Elbrit Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Coimbatore.
Charges
A charge with The South Indian Bank Limited of Rs. 540.39 Lakh registered on 25 Sep 2019 with Charge ID 100295013 was modified on 26 Dec 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 23.18 Lakh with Charge ID 100730382 was registered on 08 Mar 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 20.10 Lakh with Charge ID 100667886 was registered on 21 Nov 2022.
17 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Elbrit Life Sciences Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Elbrit Life Sciences Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Elbrit Life Sciences Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Elbrit Life Sciences Private Limited
Elbrit Life Sciences has 11 GST registrations: 8 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
11
Active
8
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCE5937C1ZY | Tamil Nadu | Active | 01 Jul 2017 |
| 36AADCE5937C1ZS | Telangana | Active | 29 Feb 2020 |
| 34AADCE5937C1ZW | Puducherry | Active | 29 Sep 2020 |
| 29AADCE5937C2ZM | Karnataka | Active | 28 Dec 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Elbrit Life Sciences Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Elbrit Life Sciences Private Limited
Frequently Asked Questions about Elbrit Life Sciences Private Limited
Elbrit Life Sciences is an active private limited company based in Erode, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 January 2014 (12+ years old) and is registered under CIN U74999TZ2014PTC029965.
Elbrit Life Sciences reported revenue of ₹41.77 Cr for FY 2024 (up 39% YoY).
Elbrit Life Sciences has 4 current directors:
- Kailasanathan Senthilkumar Prakash - Managing Director
- Karukkupalayam Murugesan Nivedha - Whole-Time Director
- Senthilkumar Kailasanathan - Whole-Time Director
- Muruhgesan Marappagounder - Director
Elbrit Life Sciences reported a net profit of ₹1.16 Cr (net margin 2.8%) and EBITDA of ₹3.05 Cr (EBITDA margin 7.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Elbrit Life Sciences is 42% over three years and 26% over five years. In the latest year (FY 2024) revenue rose 39%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Elbrit Life Sciences is 33AADCE5937C1ZY, registered in Tamil Nadu. The company has 11 GST registrations in all, of which 8 are active and 3 are cancelled or inactive. Other active GSTINs include 36AADCE5937C1ZS (Telangana), 34AADCE5937C1ZW (Puducherry), 29AADCE5937C2ZM (Karnataka).
The CIN (Corporate Identification Number) of Elbrit Life Sciences is U74999TZ2014PTC029965. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elbrit Life Sciences has 20 court cases on record: 19 filed by the company. 1 is pending. Most are in the high courts.
Elbrit Life Sciences was incorporated on 18 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Coimbatore.
Elbrit Life Sciences has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹10 Lakh; the latest was in June 2017.
The peers of Elbrit Life Sciences by revenue are Supercure Biotech Private Limited, International Ingredients & Excipients Private Limited, Samrudh Pharmacare Private Limited, Mediart Lifesciences Private Limited, Aap Pharma Technologies India Private Limited and 5 more, all in the Pharma industry (Formulations).